JPRN-jRCT2080223015未知1 期
A Phase 1 Study of the Safety, Tolerability, Pharmacokinetics and Immunoregulatory Activity of Urelumab (BMS-663513) in Subjects with Advanced and/or Metastatic Malignant Tumors
试验速览
- 阶段
- 1 期
- 入组人数
- 18
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 ot applicable（—）
- 性别
- All
入选标准
- •Previously treated advanced malignant solid tumor
- •Eastern Cooperative Oncology Group (ECOG) performance status less than or equal to 1
- •For certain subjects, willing and able to provide pre-treatment tumor sample
排除标准
- •Known or suspected central nervous system metastases or central nervous system as the only source of disease
- •Prior malignancy (with some exceptions per protocol)
- •Active, known or suspected autoimmune disease
研究者
相似试验
进行中（未招募）
不适用
Phase 1B Study of the Safety, Tolerance, and Pharmacokinetics of Oral Posaconazole in Immunocompromised Children With NeutropeniaTreatment and prophylaxis of invasive fungal infectionsoropharyngeal candidiasis (OPC) and refractory OPC.MedDRA version: 17.1Level: PTClassification code 10050346Term: Oropharyngeal candidiasisSystem Organ Class: 10021881 - Infections and infestationsEUCTR2007-004645-15-DEMerck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.108
已完成
不适用
Phase 1B Study of the Safety, Tolerance, and Pharmacokinetics of Oral Posaconazole in Immunocompromised Children With NeutropenialeukemiaNL-OMON39331Merck Sharp & Dohme (MSD)23
进行中（未招募）
不适用
A study to look at safety and acceptance of Posaconazole (study drug) given by mouth to children with a blood illness.Treatment and prophylaxis of invasive fungal infectionsMedDRA version: 14.1Level: LLTClassification code 10062642Term: Invasive mycosisSystem Organ Class: 100000004862EUCTR2007-004645-15-GRSchering Plough Research Institute, A Division of Schering Corporation108
进行中（未招募）
1 期
Phase 1B Study of the Safety, Tolerance, and Pharmacokinetics of Oral Posaconazole in Immunocompromised Children With Neutropenia - NDtreatment and prophylaxis of invasive fungal infectionsoropharyngeal candidiasis (OPC) and refractory OPCMedDRA version: 9.1 Level: LLT Classification code 10050346 Term: Oropharyngeal candidiasisMedDRA version: 9.1 Level: HLGT Classification code 10017528 Term: Fungal infectious disordersEUCTR2007-004645-15-ITSchering Plough Research Institute142
进行中（未招募）
不适用
Phase 1B Study of the Safety, Tolerance, and Pharmacokinetics of Oral Posaconazole in Immunocompromised Children With NeutropeniaEUCTR2007-004645-15-NLSchering Plough Research Institute, A Division of Schering Corporation108